Clinical trial
The Selection of Initial Treatment Regimens for Adolescent Nephrotic Syndrome: A Multicenter Real-World Study.
NCT07071597 is registered in ClinicalTrials.gov with Nanjing Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Selection of Initial Treatment Regimens for Adolescent Nephrotic Syndrome: A Multicenter Real-World Study.
- Lead sponsor
- Nanjing Children's Hospital
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- June 1, 2025
- Completion date
- December 31, 2026
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adolescent, biopsy, nephrotic syndrome